Martell Christopher's Form 4 filing
Candel Therapeutics, Inc. (CADL) · filed Dec 12, 2022
- Accession no.
- 0001209191-22-060693
- Filed
- Dec 12, 2022
- Trade date
- Dec 8-9, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $51.1K. It was filed 4 days after the trade.
This filing was later replaced by the amendment 0000899243-23-005523 (Feb 17, 2023). Trade tables on this site use the amended version.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Martell ChristopherCIK 0001873465 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 8, 2022 | Common Stock | PPurchaseAcquired | +3,050 | $1.68 | +$5,124 | 128,050 | Direct | |
| Dec 9, 2022 | Common Stock | PPurchaseAcquired | +23,950 | $1.92 | +$45,984 | 152,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.